CT screening for lung cancer: past and ongoing studies

Area of Science:

• Pulmonology
• Radiology
• Oncology

Background:

• Traditional randomized clinical trials (RCTs) for lung cancer screening using chest radiography were flawed and showed no benefit.
• Computed tomography (CT) offers superior visualization of small lung cancers compared to chest radiography.
• The Early Lung Cancer Action Project (ELCAP) established a screening regimen to manage false positives and biopsies.

Purpose of the Study:

• To evaluate the effectiveness and outcomes of lung cancer screening using computed tomography (CT) based on the International Early Lung Cancer Action Project (I-ELCAP) protocol.
• To assess the diagnostic accuracy, stage at diagnosis, and cure rates of lung cancer detected through CT screening.
• To determine the cost-effectiveness of CT screening for lung cancer.

Main Methods:

• Implementation of the updated International (I)-ELCAP protocol for CT lung cancer screening.
• Detailed regimen including initial CT parameters, positive result definition, and subsequent work-up procedures.
• Analysis of screening cycle frequency, screen-diagnosis rates, stage at diagnosis, tumor size, and patient outcomes.

Main Results:

• Low frequency of positive screening results (15% baseline, 6% repeat cycles) with a high rate of screen-diagnosed cancers (≥97%).
• Over 80% of screen-diagnosed cancers were Stage I, with a median diameter of 8 mm on repeat screening.
• Estimated 8-year cure rates of 95-98% for resected screen-diagnosed lung cancers, suggesting an overall cure rate potentially exceeding 70% with I-ELCAP screening.

Conclusions:

• CT screening, following the I-ELCAP regimen, is highly effective in detecting lung cancers at early stages.
• CT screening demonstrates significantly higher cure rates compared to usual care or chest radiography screening.
• CT lung cancer screening appears to be a cost-effective strategy for improving patient survival.